Joint Formulary & PAD

Cannabis (medicinal) - Tuberous sclerosis complex

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Oral solution
Associated Icons :
BNF SPC
CD
NFD2
NHSE
Restrictions / Comments :
Important
Specilaist initiation only.

PAD Profile

ChemicalSubstance :
Cannabis (medicinal)
Indication :
Tuberous sclerosis complex
Group Name :
Keywords :
TSC, seizures associated with tuberous sclerosis complex, cannabis, cannabis-based products for medicinal use, CBPM
Brand Names Include :
Epidyolex
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1

Other Indications

Below are listed other indications that Cannabis (medicinal) is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Tuberous sclerosis complex.

  • No records returned.

Committee Recommendations (2)

NHS England guidance to support clinicians on the prescribing of cannabis-based products for medicinal use:

https://www.england.nhs.uk/medicines-2/support-for-prescribers/cannabis-based-products-for-medicinal-use/

This drug falls under the responsibility of NHS England Specialised Commissioning and should therefore not be prescribed in Primary Care.

Clinicians / specialists within the Acute setting should only prescribe in line with their Trust formulary / pharmacy advice.

GPs should ensure that patient medication records include any medicine for which prescribing remains the responsibility of secondary or tertiary care. This will ensure that GP records, which are accessed by other healthcare providers, are a true and accurate reflection of the patient’s medication